Published in N Engl J Med on January 27, 1994
How I treat paroxysmal nocturnal hemoglobinuria. Blood (2009) 1.97
Neurology of inherited glycosylation disorders. Lancet Neurol (2012) 1.82
Clonal populations of hematopoietic cells with paroxysmal nocturnal hemoglobinuria genotype and phenotype are present in normal individuals. Proc Natl Acad Sci U S A (1999) 1.75
Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein. J Exp Med (1995) 1.74
Improved detection and characterization of paroxysmal nocturnal hemoglobinuria using fluorescent aerolysin. Am J Clin Pathol (2000) 1.66
The role of telomere biology in bone marrow failure and other disorders. Mech Ageing Dev (2007) 1.56
Role of decay-accelerating factor in regulating complement activation on the erythrocyte surface as revealed by gene targeting. Proc Natl Acad Sci U S A (1999) 1.42
Paroxysmal nocturnal hemoglobinuria. Blood (2014) 1.39
Biosynthesis of glycosylphosphatidylinositol membrane anchors. Biochem J (1995) 1.25
Resistance to apoptosis caused by PIG-A gene mutations in paroxysmal nocturnal hemoglobinuria. Proc Natl Acad Sci U S A (1997) 1.10
Neutral evolution in paroxysmal nocturnal hemoglobinuria. Proc Natl Acad Sci U S A (2008) 1.05
Isolation and characterization of a Chinese hamster ovary (CHO) mutant defective in the second step of glycosylphosphatidylinositol biosynthesis. Biochem J (1996) 0.93
Antibody selection against CD52 produces a paroxysmal nocturnal haemoglobinuria phenotype in human lymphocytes by a novel mechanism. Biochem J (1997) 0.88
Expression of glycosylphosphatidylinositol-anchored CD59 on target cells enhances human NK cell-mediated cytotoxicity. J Immunol (2006) 0.83
Complement receptors and regulatory proteins: immune adherence revisited and abuse by microorganisms. Clin Exp Immunol (1994) 0.83
Role of complement and complement regulatory proteins in the complications of diabetes. Endocr Rev (2015) 0.82
PIG-A--the target gene in paroxysmal nocturnal hemoglobinuria. N Engl J Med (1994) 0.82
Characterization of a glycosyl-phosphatidylinositol anchor-deficient subline of Raji cells. An analysis of the functional importance of complement inhibitors on the Raji cell line. Immunology (1995) 0.81
Paroxysmal nocturnal hemoglobinuria: a complement-mediated hemolytic anemia. Hematol Oncol Clin North Am (2015) 0.80
Paroxysmal nocturnal hemoglobinuria and the glycosylphosphatidylinositol anchor. J Clin Invest (1994) 0.80
Paroxysmal nocturnal hemoglobinuria and telomere length predicts response to immunosuppressive therapy in pediatric aplastic anemia. Haematologica (2015) 0.79
Complement inhibition to treat myocardial infarction? BMJ Case Rep (2011) 0.78
A new blood group antigen is defined by anti-CD59, detected in a CD59-deficient patient. Transfusion (2014) 0.77
Complement blockade with a C1 esterase inhibitor in paroxysmal nocturnal hemoglobinuria. Exp Hematol (2014) 0.77
Hemoglobinuria misidentified as hematuria: review of discolored urine and paroxysmal nocturnal hemoglobinuria. Clin Med Insights Blood Disord (2013) 0.76
Expression of cryptantigen Th on paroxysmal nocturnal hemoglobinuria erythrocytes in association with a hemolytic exacerbation. J Clin Invest (1995) 0.75
The genetic defect of PNH. Clin Exp Immunol (1994) 0.75
Long-term outcome of fludarabine-based reduced-intensity allogeneic hematopoietic cell transplantation for debilitating paroxysmal nocturnal hemoglobinuria. Biol Blood Marrow Transplant (2014) 0.75
Management of thrombosis in paroxysmal nocturnal hemoglobinuria: a clinician's guide. Ther Adv Hematol (2016) 0.75
Mutation analysis of the PIG-A gene in Korean patients with paroxysmal nocturnal haemoglobinuria. J Clin Pathol (2002) 0.75
Cerebral Stroke in a Teenage Girl with Paroxysmal Nocturnal Hemoglobinuria. Hematol Rep (2017) 0.75
Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes. J Exp Med (1984) 5.47
Mutations in the hepatocyte nuclear factor-1alpha gene in maturity-onset diabetes of the young (MODY3) Nature (1996) 5.32
Stat3 activation is responsible for IL-6-dependent T cell proliferation through preventing apoptosis: generation and characterization of T cell-specific Stat3-deficient mice. J Immunol (1998) 4.74
Progress in gastric cancer surgery in Japan and its limits of radicality. World J Surg (1987) 4.06
Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria. Cell (1993) 4.04
A novel reporter mouse strain that expresses enhanced green fluorescent protein upon Cre-mediated recombination. FEBS Lett (2000) 4.03
Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus. N Engl J Med (1993) 3.96
Sterol regulatory element-binding protein-1 as a key transcription factor for nutritional induction of lipogenic enzyme genes. J Biol Chem (1999) 3.72
Diagnostic criteria for primary osteoporosis: year 2000 revision. J Bone Miner Metab (2001) 3.43
Distribution of decay-accelerating factor in the peripheral blood of normal individuals and patients with paroxysmal nocturnal hemoglobinuria. J Exp Med (1985) 3.33
Molecular biology of mammalian glucose transporters. Diabetes Care (1990) 3.33
Keratinocyte-specific ablation of Stat3 exhibits impaired skin remodeling, but does not affect skin morphogenesis. EMBO J (1999) 3.19
Promoter analysis of the mouse sterol regulatory element-binding protein-1c gene. J Biol Chem (2000) 3.11
Inhibition by kasugamycin of initiation complex formation on 30S ribosomes. Biochem Biophys Res Commun (1971) 3.02
Recurrence of early gastric cancer. Follow-up of 1475 patients and review of the Japanese literature. Cancer (1993) 2.90
Targeted disruption of hormone-sensitive lipase results in male sterility and adipocyte hypertrophy, but not in obesity. Proc Natl Acad Sci U S A (2000) 2.90
Nonsense mutation in the glucokinase gene causes early-onset non-insulin-dependent diabetes mellitus. Nature (1992) 2.86
IL-2-induced activation-induced cell death is inhibited in IL-15 transgenic mice. Proc Natl Acad Sci U S A (2000) 2.80
The cloning of PIG-A, a component in the early step of GPI-anchor biosynthesis. Science (1993) 2.77
Gender difference in delays to diagnosis and health care seeking behaviour in a rural area of Nepal. Int J Tuberc Lung Dis (2001) 2.75
Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells. Cancer Res (1999) 2.74
Identification of liver X receptor-retinoid X receptor as an activator of the sterol regulatory element-binding protein 1c gene promoter. Mol Cell Biol (2001) 2.68
A novel recovery system for cultured cells using plasma-treated polystyrene dishes grafted with poly(N-isopropylacrylamide). J Biomed Mater Res (1993) 2.67
Mapping of epitopes, glycosylation sites, and complement regulatory domains in human decay accelerating factor. J Immunol (1992) 2.64
Efficient chromosomal transposition of a Tc1/mariner- like transposon Sleeping Beauty in mice. Proc Natl Acad Sci U S A (2001) 2.51
Lymph node metastases of gastric cancer. General pattern in 1931 patients. Ann Surg (1989) 2.45
Association of structural polymorphisms in the human period3 gene with delayed sleep phase syndrome. EMBO Rep (2001) 2.43
Sequence and functional characterization of a third inositol trisphosphate receptor subtype, IP3R-3, expressed in pancreatic islets, kidney, gastrointestinal tract, and other tissues. J Biol Chem (1993) 2.42
Platelet-derived growth factor stimulates tyrosine-specific protein kinase activity in Swiss mouse 3T3 cell membranes. Proc Natl Acad Sci U S A (1982) 2.39
Fructose transporter in human spermatozoa and small intestine is GLUT5. J Biol Chem (1992) 2.35
Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with selective serotonin reuptake inhibitor efficacy in depressed patients. Mol Psychiatry (2006) 2.29
A novel highly specific and potent inhibitor of calmodulin-dependent protein kinase II. Biochem Biophys Res Commun (1995) 2.19
Requirement of DNase II for definitive erythropoiesis in the mouse fetal liver. Science (2001) 2.17
Structure and function of mammalian facilitative sugar transporters. J Biol Chem (1993) 2.14
Presenilin-1 mutations downregulate the signalling pathway of the unfolded-protein response. Nat Cell Biol (1999) 2.14
Defective stratum corneum and early neonatal death in mice lacking the gene for transglutaminase 1 (keratinocyte transglutaminase). Proc Natl Acad Sci U S A (1998) 2.12
Fetal liver development requires a paracrine action of oncostatin M through the gp130 signal transducer. EMBO J (1999) 2.08
Mechanism of protein synthesis inhibition by fusidic acid and related antibiotics. Biochem Biophys Res Commun (1968) 2.06
Developmental abnormalities of glycosylphosphatidylinositol-anchor-deficient embryos revealed by Cre/loxP system. Lab Invest (1999) 2.06
Expression levels of DNA methyltransferase genes do not correlate with p15INK4B gene methylation in myelodysplastic syndromes. Leukemia (2003) 2.06
Mechanism of cell detachment from temperature-modulated, hydrophilic-hydrophobic polymer surfaces. Biomaterials (1995) 2.04
Skin lesions during intravenous hyperalimentation: zinc deficiency. 1976. Nutrition (1992) 2.03
Downregulation of Bim, a proapoptotic relative of Bcl-2, is a pivotal step in cytokine-initiated survival signaling in murine hematopoietic progenitors. Mol Cell Biol (2001) 2.03
Suppression of interleukin-3-induced gene expression by a C-terminal truncated Stat5: role of Stat5 in proliferation. EMBO J (1996) 2.02
Tissue-specific knockout of the mouse Pig-a gene reveals important roles for GPI-anchored proteins in skin development. Proc Natl Acad Sci U S A (1997) 1.97
New method to evaluate the therapeutic value of lymph node dissection for gastric cancer. Br J Surg (1995) 1.96
Cervical pedicle screw insertion: assessment of safety and accuracy with computer-assisted image guidance. J Spinal Disord (2000) 1.95
Absence of anticardiolipin antibody in non-treated and heat-inactivated normal human sera. Thromb Res (1992) 1.94
Measurement of circulating thyroid microsomal antibodies by the tanned red cell haemagglutination technique: its usefulness in the diagnosis of autoimmune thyroid diseases. Clin Endocrinol (Oxf) (1976) 1.92
Aldehyde dehydrogenase genotypes in Japanese alcoholics. Lancet (1994) 1.91
Mutations in the FIE and MEA genes that encode interacting polycomb proteins cause parent-of-origin effects on seed development by distinct mechanisms. Plant Cell (2000) 1.90
Decay-accelerating factor is present on cultured human umbilical vein endothelial cells. J Exp Med (1986) 1.88
Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma. Lancet (1990) 1.88
Fractalkine, a CX3C chemokine, is expressed by dendritic cells and is up-regulated upon dendritic cell maturation. Eur J Immunol (1999) 1.88
A new method for prosthetic valve replacement in congenital aortic stenosis associated with hypoplasia of the aortic valve ring. J Thorac Cardiovasc Surg (1975) 1.87
Amelioration of lytic abnormalities of paroxysmal nocturnal hemoglobinuria with decay-accelerating factor. Proc Natl Acad Sci U S A (1985) 1.87
Evolution of beta-cell dysfunction in the male Zucker diabetic fatty rat. Diabetes (1995) 1.87
Involvement of Calmodulin and Calmodulin-Dependent Myosin Light Chain Kinase in Blue Light-Dependent H Pumping by Guard Cell Protoplasts from Vicia faba L. Plant Physiol (1992) 1.87
Monoclonal antibodies to mouse complement receptor type 1 (CR1). Their use in a distribution study showing that mouse erythrocytes and platelets are CR1-negative. J Immunol (1988) 1.86
Insulin secretory abnormalities in subjects with hyperglycemia due to glucokinase mutations. J Clin Invest (1994) 1.82
Paroxysmal nocturnal haemoglobinuria (PNH) is caused by somatic mutations in the PIG-A gene. EMBO J (1994) 1.80
Quantitative analysis of genomic polymorphism of herpes simplex virus type 1 strains from six countries: studies of molecular evolution and molecular epidemiology of the virus. J Gen Virol (1994) 1.79
Troglitazone inhibits atherosclerosis in apolipoprotein E-knockout mice: pleiotropic effects on CD36 expression and HDL. Arterioscler Thromb Vasc Biol (2001) 1.78
Decreased functional connectivity of EEG theta-frequency activity in first-episode, neuroleptic-naïve patients with schizophrenia: preliminary results. Schizophr Res (2001) 1.77
Adult-onset spinocerebellar dysfunction caused by a mutation in the gene for the alpha-tocopherol-transfer protein. N Engl J Med (1995) 1.77
Cloning and functional comparison of kappa and delta opioid receptors from mouse brain. Proc Natl Acad Sci U S A (1993) 1.77
Hepatocellular carcinoma with portal vein tumor thrombus: embolization of arterioportal shunts. Radiology (1997) 1.74
Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein. J Exp Med (1995) 1.74
Randomized controlled trial of adjuvant uracil-tegafur versus surgery alone for serosa-negative, locally advanced gastric cancer. Br J Surg (2007) 1.73
Analytical chemical studies on amino sugars. II. Determination of hexosamines using 3-methyl-2-benzothiazolone hydrazone hydrochloride. Chem Pharm Bull (Tokyo) (1969) 1.72
Epstein-Barr virus genome-positive T lymphocytes in a boy with chronic active EBV infection associated with Kawasaki-like disease. Nature (1988) 1.71
[Electron microscopic studies on peroxidase and acid phosphatase reaction in human leukocytes (in normal and leukemic cells and on phagocytosis)]. Nihon Ketsueki Gakkai Zasshi (1966) 1.70
Clinical experiences in Sakai City Hospital during the massive outbreak of enterohemorrhagic Escherichia coli O157 infections in Sakai City, 1996. Pediatr Int (1999) 1.69
Critical roles of glycosylphosphatidylinositol for Trypanosoma brucei. Proc Natl Acad Sci U S A (2000) 1.69
A crucial role of sterol regulatory element-binding protein-1 in the regulation of lipogenic gene expression by polyunsaturated fatty acids. J Biol Chem (1999) 1.68
In vivo inhibition of the antibody response by a complement receptor-specific monoclonal antibody. J Exp Med (1990) 1.67
Paroxysmal nocturnal hemoglobinuria: An acquired genetic disease. Am J Hematol (1999) 1.66
Thiazolidinediones provide better renoprotection than insulin in an obese, hypertensive type II diabetic rat model. Kidney Int (2007) 1.66
Expression cloning of PIG-L, a candidate N-acetylglucosaminyl-phosphatidylinositol deacetylase. J Biol Chem (1997) 1.65
Suppression of mitochondrial succinate dehydrogenase, a primary target of beta-amyloid, and its derivative racemized at Ser residue. J Neurochem (1995) 1.65
Sonographic findings of anomalous position of the gallbladder. Abdom Imaging (1998) 1.64
Combined laminectomy and thoracoscopic resection of dumbbell-type thoracic cord tumor. Spine (Phila Pa 1976) (2001) 1.64
Prevalence of hepatitis B or C virus infections in patients with non-Hodgkin's lymphoma. J Gastroenterol Hepatol (2001) 1.63
Activation of a recombinant membrane type 1-matrix metalloproteinase (MT1-MMP) by furin and its interaction with tissue inhibitor of metalloproteinases (TIMP)-2. FEBS Lett (1996) 1.63